1. Home
  2. RDHL vs LDWY Comparison

RDHL vs LDWY Comparison

Compare RDHL & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • LDWY
  • Stock Information
  • Founded
  • RDHL 2009
  • LDWY 1990
  • Country
  • RDHL Israel
  • LDWY United States
  • Employees
  • RDHL N/A
  • LDWY N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • LDWY Advertising
  • Sector
  • RDHL Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • RDHL 6.8M
  • LDWY 6.9M
  • IPO Year
  • RDHL N/A
  • LDWY 1991
  • Fundamental
  • Price
  • RDHL $4.76
  • LDWY $4.12
  • Analyst Decision
  • RDHL
  • LDWY
  • Analyst Count
  • RDHL 0
  • LDWY 0
  • Target Price
  • RDHL N/A
  • LDWY N/A
  • AVG Volume (30 Days)
  • RDHL 9.0K
  • LDWY 5.3K
  • Earning Date
  • RDHL 04-07-2025
  • LDWY 03-31-2025
  • Dividend Yield
  • RDHL N/A
  • LDWY N/A
  • EPS Growth
  • RDHL N/A
  • LDWY N/A
  • EPS
  • RDHL N/A
  • LDWY N/A
  • Revenue
  • RDHL $3,707,000.00
  • LDWY $31,581,000.00
  • Revenue This Year
  • RDHL $224.90
  • LDWY N/A
  • Revenue Next Year
  • RDHL $82.69
  • LDWY N/A
  • P/E Ratio
  • RDHL N/A
  • LDWY N/A
  • Revenue Growth
  • RDHL N/A
  • LDWY N/A
  • 52 Week Low
  • RDHL $4.76
  • LDWY $3.02
  • 52 Week High
  • RDHL $20.28
  • LDWY $6.88
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 26.11
  • LDWY 45.61
  • Support Level
  • RDHL $5.20
  • LDWY $3.85
  • Resistance Level
  • RDHL $5.50
  • LDWY $4.75
  • Average True Range (ATR)
  • RDHL 0.23
  • LDWY 0.17
  • MACD
  • RDHL -0.07
  • LDWY -0.01
  • Stochastic Oscillator
  • RDHL 0.00
  • LDWY 30.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: